Biocon pulls application for EU approval of two drugs Ruby Khatun Khatun17 Aug 2017 12:01 PM ISTBiocon Ltd has withdrawn its application seeking European Union approval for two drugs after the EU drugs regulator sought re-inspection of their...
Cipla shares surge over 6 percent after Q1 earnings Ruby Khatun Khatun17 Aug 2017 11:59 AM ISTNew Delhi: Shares of drug major Cipla rose over 6 per cent after the company reported 23.63 per cent rise in consolidated net profit for the first...
Zydus Cadila gets USFDA nod for blood pressure drug Ruby Khatun Khatun17 Aug 2017 11:58 AM ISTNew Delhi: Cadila Healthcare on Wednesday said its group firm Zydus Cadila has received final approval from the US health regulator to market blood...
Apollo Hospitals Q1 net profit tumbles 51 percent to Rs 35.21 crore Ruby Khatun Khatun16 Aug 2017 12:03 PM ISTNew Delhi: Apollo Hospitals Enterprise on Monday reported 51.21 per cent dip in standalone net profit to Rs 35.21 crore for June 2017 quarter, mainly...
Zydus settles patent case over Aptalis drug Canasa Ruby Khatun Khatun16 Aug 2017 11:00 AM ISTNew Delhi: Zydus group firm Cadila Healthcare on Monday said patent litigation relating to Aptalis' drug Canasa used for treatment of ulcerative...
India aims to revamp health scheme by lowering cost Ruby Khatun Khatun16 Aug 2017 10:30 AM ISTNew Delhi: India's health ministry has trimmed its cost estimates for extending its main public health programme by 25 percent after criticism from a...
Far-right clashes: Merck CEO quits Trump panel Ruby Khatun Khatun16 Aug 2017 10:00 AM ISTCHARLOTTESVILLE: US President Donald Trump faced renewed pressure on Monday to respond more forcefully to a violent white-nationalist rally in...
Chinas Fosun, Shanghai Pharma say bid for stake in US drugmaker Arbor Ruby Khatun Khatun16 Aug 2017 9:30 AM ISTHONG KONG: A unit of China's Fosun Group and Shanghai Pharmaceuticals Holding Co are among bidders for a stake in U.S. speciality drugmaker Arbor...
Natco Pharma gets USFDA nod to market renal disease drug Ruby Khatun Khatun16 Aug 2017 9:00 AM ISTNew Delhi: Natco Pharma on Monday said it has received approval from the US health regulator to market Lanthanum Carbonate chewable tablets used in...
Sanofi Files Suit in the US to Defend its Patent Rights on Lantus Ruby Khatun Khatun15 Aug 2017 10:30 AM ISTParis, France: Sanofi announced that it filed a patent infringement suit against Merck Sharp & Dohme Corp. (“Merck”) on August 8, 2017 in the...
Gilead announces USFDA Priority Review Designation for FDC of Bictegravir, Emtricitabine, Tenofovir Alafenamide to treat HIV Ruby Khatun Khatun15 Aug 2017 10:15 AM ISTFOSTER CITY, Calif: Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted priority review for the company’s New...
Non Introduction of New Oncology Medicines- Anupriya Patel Ruby Khatun Khatun15 Aug 2017 9:55 AM ISTFifteen anticancer drugs have been approved by the Central Licensing Authority i.e. the Drugs Controller General (India) for import/manufacture and...
